CHMP5 and acute lymphoblastic leukemia: The poor overall survival of T-ALL patients with the highest expression of CHMP5 suggests that CHMP5 might contribute to patient T-ALL response to treatment and prompted us to investigate how CHMP5-deficiency impacted whether T-ALL cell response to chemotherapy.